Researchers at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) have designed influenza vaccine candidates based on group 2 influenza hemagglutinin ...

"The conserved influenza hemagglutinin stem, which is a target of cross-neutralizing antibodies, is now used in vaccine strategies focused on protecting against influenza pandemics," Mantus asserted.

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...

One age group are more likely to have antibodies that bind to the H5N1 avian flu virus, new research has found.

If this occurs, H5N1 could potentially start spreading from human to human. Influenza viruses are covered with two lollipop-shaped proteins called hemagglutinin and neuraminidase, for which the ...

In this NEJM Outbreaks Update, Editor-in-Chief Eric Rubin and Deputy Editor Lindsey Baden are joined by veterinarian and virologist Yoshihiro Kawaoka to discuss avian influenza and its current ...

Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

An electron microscope image of the CDC’s recreated 1918 Influenza virus, seen here, 18 hours after infection. Courtesy: CDC/Dr. Terrence Tumpey Despite recent advances in microbiology, early ...